SUBSTITUTED PHENYL COMPOUND

PROBLEM TO BE SOLVED: To provide a substituted phenyl compound having prostaglandin E-like agonist action, particularly EP2-selective agonist action, wherein the substituted phenyl compound has excellent pulmonary fibroblast proliferation inhibitory action and is suitable for pneumonitis/pulmonary f...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: KANDA TOMOKO, USHIYAMA SHIGERU, IWASE NORIAKI, SHIBAKAWA NOBUHIKO, YONEDA KENJI
Format: Patent
Sprache:eng ; jpn
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator KANDA TOMOKO
USHIYAMA SHIGERU
IWASE NORIAKI
SHIBAKAWA NOBUHIKO
YONEDA KENJI
description PROBLEM TO BE SOLVED: To provide a substituted phenyl compound having prostaglandin E-like agonist action, particularly EP2-selective agonist action, wherein the substituted phenyl compound has excellent pulmonary fibroblast proliferation inhibitory action and is suitable for pneumonitis/pulmonary fibrosis therapeutic and/or preventive agents.SOLUTION: This invention relates to a substituted phenyl compound represented by formula (I) or pharmacologically acceptable salt thereof (Ris a carboxy group that may be protected; Q is O or a group -CH-; W is N or a group -CH=; Ris an ethoxy group, a 1-propenyl group or a 1-propynyl group; Z is a phenyl group or a specific group).SELECTED DRAWING: None 【課題】プロスタグランジンE2様のアゴニスト作用、特にEP2選択的なアゴニスト作用を有する置換フェニル化合物は、優れた肺線維芽細胞増殖抑制作用を有し、間質性肺炎・肺線維症治療薬及び/又は予防薬の提供。【解決手段】式(I)で表される置換フェニル化合物又はその薬理上許容される塩。(R1は保護されていてもよいカルボキシ基;QはO又は基−CH2−;WはN又は基−CH=;R2はエトキシ基、1−プロペニル基又は1−プロピニル基;Zはフェニル基又は特定の基を示す)【選択図】なし
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_JP2017206444A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>JP2017206444A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_JP2017206444A3</originalsourceid><addsrcrecordid>eNrjZJAODnUKDvEMCQ1xdVEI8HD1i_RRcPb3DfAP9XPhYWBNS8wpTuWF0twMSm6uIc4euqkF-fGpxQWJyal5qSXxXgFGBobmRgZmJiYmjsZEKQIAtOIhRw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>SUBSTITUTED PHENYL COMPOUND</title><source>esp@cenet</source><creator>KANDA TOMOKO ; USHIYAMA SHIGERU ; IWASE NORIAKI ; SHIBAKAWA NOBUHIKO ; YONEDA KENJI</creator><creatorcontrib>KANDA TOMOKO ; USHIYAMA SHIGERU ; IWASE NORIAKI ; SHIBAKAWA NOBUHIKO ; YONEDA KENJI</creatorcontrib><description>PROBLEM TO BE SOLVED: To provide a substituted phenyl compound having prostaglandin E-like agonist action, particularly EP2-selective agonist action, wherein the substituted phenyl compound has excellent pulmonary fibroblast proliferation inhibitory action and is suitable for pneumonitis/pulmonary fibrosis therapeutic and/or preventive agents.SOLUTION: This invention relates to a substituted phenyl compound represented by formula (I) or pharmacologically acceptable salt thereof (Ris a carboxy group that may be protected; Q is O or a group -CH-; W is N or a group -CH=; Ris an ethoxy group, a 1-propenyl group or a 1-propynyl group; Z is a phenyl group or a specific group).SELECTED DRAWING: None 【課題】プロスタグランジンE2様のアゴニスト作用、特にEP2選択的なアゴニスト作用を有する置換フェニル化合物は、優れた肺線維芽細胞増殖抑制作用を有し、間質性肺炎・肺線維症治療薬及び/又は予防薬の提供。【解決手段】式(I)で表される置換フェニル化合物又はその薬理上許容される塩。(R1は保護されていてもよいカルボキシ基;QはO又は基−CH2−;WはN又は基−CH=;R2はエトキシ基、1−プロペニル基又は1−プロピニル基;Zはフェニル基又は特定の基を示す)【選択図】なし</description><language>eng ; jpn</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2017</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20171124&amp;DB=EPODOC&amp;CC=JP&amp;NR=2017206444A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20171124&amp;DB=EPODOC&amp;CC=JP&amp;NR=2017206444A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>KANDA TOMOKO</creatorcontrib><creatorcontrib>USHIYAMA SHIGERU</creatorcontrib><creatorcontrib>IWASE NORIAKI</creatorcontrib><creatorcontrib>SHIBAKAWA NOBUHIKO</creatorcontrib><creatorcontrib>YONEDA KENJI</creatorcontrib><title>SUBSTITUTED PHENYL COMPOUND</title><description>PROBLEM TO BE SOLVED: To provide a substituted phenyl compound having prostaglandin E-like agonist action, particularly EP2-selective agonist action, wherein the substituted phenyl compound has excellent pulmonary fibroblast proliferation inhibitory action and is suitable for pneumonitis/pulmonary fibrosis therapeutic and/or preventive agents.SOLUTION: This invention relates to a substituted phenyl compound represented by formula (I) or pharmacologically acceptable salt thereof (Ris a carboxy group that may be protected; Q is O or a group -CH-; W is N or a group -CH=; Ris an ethoxy group, a 1-propenyl group or a 1-propynyl group; Z is a phenyl group or a specific group).SELECTED DRAWING: None 【課題】プロスタグランジンE2様のアゴニスト作用、特にEP2選択的なアゴニスト作用を有する置換フェニル化合物は、優れた肺線維芽細胞増殖抑制作用を有し、間質性肺炎・肺線維症治療薬及び/又は予防薬の提供。【解決手段】式(I)で表される置換フェニル化合物又はその薬理上許容される塩。(R1は保護されていてもよいカルボキシ基;QはO又は基−CH2−;WはN又は基−CH=;R2はエトキシ基、1−プロペニル基又は1−プロピニル基;Zはフェニル基又は特定の基を示す)【選択図】なし</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2017</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZJAODnUKDvEMCQ1xdVEI8HD1i_RRcPb3DfAP9XPhYWBNS8wpTuWF0twMSm6uIc4euqkF-fGpxQWJyal5qSXxXgFGBobmRgZmJiYmjsZEKQIAtOIhRw</recordid><startdate>20171124</startdate><enddate>20171124</enddate><creator>KANDA TOMOKO</creator><creator>USHIYAMA SHIGERU</creator><creator>IWASE NORIAKI</creator><creator>SHIBAKAWA NOBUHIKO</creator><creator>YONEDA KENJI</creator><scope>EVB</scope></search><sort><creationdate>20171124</creationdate><title>SUBSTITUTED PHENYL COMPOUND</title><author>KANDA TOMOKO ; USHIYAMA SHIGERU ; IWASE NORIAKI ; SHIBAKAWA NOBUHIKO ; YONEDA KENJI</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_JP2017206444A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; jpn</language><creationdate>2017</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>KANDA TOMOKO</creatorcontrib><creatorcontrib>USHIYAMA SHIGERU</creatorcontrib><creatorcontrib>IWASE NORIAKI</creatorcontrib><creatorcontrib>SHIBAKAWA NOBUHIKO</creatorcontrib><creatorcontrib>YONEDA KENJI</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>KANDA TOMOKO</au><au>USHIYAMA SHIGERU</au><au>IWASE NORIAKI</au><au>SHIBAKAWA NOBUHIKO</au><au>YONEDA KENJI</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>SUBSTITUTED PHENYL COMPOUND</title><date>2017-11-24</date><risdate>2017</risdate><abstract>PROBLEM TO BE SOLVED: To provide a substituted phenyl compound having prostaglandin E-like agonist action, particularly EP2-selective agonist action, wherein the substituted phenyl compound has excellent pulmonary fibroblast proliferation inhibitory action and is suitable for pneumonitis/pulmonary fibrosis therapeutic and/or preventive agents.SOLUTION: This invention relates to a substituted phenyl compound represented by formula (I) or pharmacologically acceptable salt thereof (Ris a carboxy group that may be protected; Q is O or a group -CH-; W is N or a group -CH=; Ris an ethoxy group, a 1-propenyl group or a 1-propynyl group; Z is a phenyl group or a specific group).SELECTED DRAWING: None 【課題】プロスタグランジンE2様のアゴニスト作用、特にEP2選択的なアゴニスト作用を有する置換フェニル化合物は、優れた肺線維芽細胞増殖抑制作用を有し、間質性肺炎・肺線維症治療薬及び/又は予防薬の提供。【解決手段】式(I)で表される置換フェニル化合物又はその薬理上許容される塩。(R1は保護されていてもよいカルボキシ基;QはO又は基−CH2−;WはN又は基−CH=;R2はエトキシ基、1−プロペニル基又は1−プロピニル基;Zはフェニル基又は特定の基を示す)【選択図】なし</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; jpn
recordid cdi_epo_espacenet_JP2017206444A
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
title SUBSTITUTED PHENYL COMPOUND
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T19%3A57%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=KANDA%20TOMOKO&rft.date=2017-11-24&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EJP2017206444A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true